Found 9 hits for monomerid = 50268434 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Calcium channel (Type L)
(Homo sapiens (Human)) | BDBM50268434
((+/-)-6-(1-methyl-1H-pyrazol-5-yl)-4-oxo-N-((tans)...)Show SMILES Cn1nccc1-c1ccc2OC3(CCN(CC3)C(=O)N[C@H]3C[C@@H]3c3ccccc3)CC(=O)c2c1 |r| Show InChI InChI=1S/C27H28N4O3/c1-30-23(9-12-28-30)19-7-8-25-21(15-19)24(32)17-27(34-25)10-13-31(14-11-27)26(33)29-22-16-20(22)18-5-3-2-4-6-18/h2-9,12,15,20,22H,10-11,13-14,16-17H2,1H3,(H,29,33)/t20-,22+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 2.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Activity at Cav 1.2 channel |
Bioorg Med Chem Lett 19: 3398-404 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.036 BindingDB Entry DOI: 10.7270/Q20C4VP7 |
More data for this Ligand-Target Pair | |
EBifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50268434
((+/-)-6-(1-methyl-1H-pyrazol-5-yl)-4-oxo-N-((tans)...)Show SMILES Cn1nccc1-c1ccc2OC3(CCN(CC3)C(=O)N[C@H]3C[C@@H]3c3ccccc3)CC(=O)c2c1 |r| Show InChI InChI=1S/C27H28N4O3/c1-30-23(9-12-28-30)19-7-8-25-21(15-19)24(32)17-27(34-25)10-13-31(14-11-27)26(33)29-22-16-20(22)18-5-3-2-4-6-18/h2-9,12,15,20,22H,10-11,13-14,16-17H2,1H3,(H,29,33)/t20-,22+/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Inhibition of human soluble epoxide hydrolase in HEK293 cells assessed as DHET production |
Bioorg Med Chem Lett 19: 3398-404 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.036 BindingDB Entry DOI: 10.7270/Q20C4VP7 |
More data for this Ligand-Target Pair | |
Epoxide hydrolase 1
(Homo sapiens (Human)) | BDBM50268434
((+/-)-6-(1-methyl-1H-pyrazol-5-yl)-4-oxo-N-((tans)...)Show SMILES Cn1nccc1-c1ccc2OC3(CCN(CC3)C(=O)N[C@H]3C[C@@H]3c3ccccc3)CC(=O)c2c1 |r| Show InChI InChI=1S/C27H28N4O3/c1-30-23(9-12-28-30)19-7-8-25-21(15-19)24(32)17-27(34-25)10-13-31(14-11-27)26(33)29-22-16-20(22)18-5-3-2-4-6-18/h2-9,12,15,20,22H,10-11,13-14,16-17H2,1H3,(H,29,33)/t20-,22+/m1/s1 | KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Inhibition of human microsomal epoxide hydrolase |
Bioorg Med Chem Lett 19: 3398-404 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.036 BindingDB Entry DOI: 10.7270/Q20C4VP7 |
More data for this Ligand-Target Pair | |
Epoxide hydrolase 2
(Rattus norvegicus) | BDBM50268434
((+/-)-6-(1-methyl-1H-pyrazol-5-yl)-4-oxo-N-((tans)...)Show SMILES Cn1nccc1-c1ccc2OC3(CCN(CC3)C(=O)N[C@H]3C[C@@H]3c3ccccc3)CC(=O)c2c1 |r| Show InChI InChI=1S/C27H28N4O3/c1-30-23(9-12-28-30)19-7-8-25-21(15-19)24(32)17-27(34-25)10-13-31(14-11-27)26(33)29-22-16-20(22)18-5-3-2-4-6-18/h2-9,12,15,20,22H,10-11,13-14,16-17H2,1H3,(H,29,33)/t20-,22+/m1/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Inhibition of rat soluble epoxide hydrolase |
Bioorg Med Chem Lett 19: 3398-404 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.036 BindingDB Entry DOI: 10.7270/Q20C4VP7 |
More data for this Ligand-Target Pair | |
EBifunctional epoxide hydrolase 2
(Homo sapiens (Human)) | BDBM50268434
((+/-)-6-(1-methyl-1H-pyrazol-5-yl)-4-oxo-N-((tans)...)Show SMILES Cn1nccc1-c1ccc2OC3(CCN(CC3)C(=O)N[C@H]3C[C@@H]3c3ccccc3)CC(=O)c2c1 |r| Show InChI InChI=1S/C27H28N4O3/c1-30-23(9-12-28-30)19-7-8-25-21(15-19)24(32)17-27(34-25)10-13-31(14-11-27)26(33)29-22-16-20(22)18-5-3-2-4-6-18/h2-9,12,15,20,22H,10-11,13-14,16-17H2,1H3,(H,29,33)/t20-,22+/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Inhibition of human soluble epoxide hydrolase |
Bioorg Med Chem Lett 19: 3398-404 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.036 BindingDB Entry DOI: 10.7270/Q20C4VP7 |
More data for this Ligand-Target Pair | |
Cytochrome P450 2D6
(Homo sapiens (Human)) | BDBM50268434
((+/-)-6-(1-methyl-1H-pyrazol-5-yl)-4-oxo-N-((tans)...)Show SMILES Cn1nccc1-c1ccc2OC3(CCN(CC3)C(=O)N[C@H]3C[C@@H]3c3ccccc3)CC(=O)c2c1 |r| Show InChI InChI=1S/C27H28N4O3/c1-30-23(9-12-28-30)19-7-8-25-21(15-19)24(32)17-27(34-25)10-13-31(14-11-27)26(33)29-22-16-20(22)18-5-3-2-4-6-18/h2-9,12,15,20,22H,10-11,13-14,16-17H2,1H3,(H,29,33)/t20-,22+/m1/s1 | PDB
UniProtKB/SwissProt UniProtKB/TrEMBL
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Inhibition of CYP2D6 |
Bioorg Med Chem Lett 19: 3398-404 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.036 BindingDB Entry DOI: 10.7270/Q20C4VP7 |
More data for this Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50268434
((+/-)-6-(1-methyl-1H-pyrazol-5-yl)-4-oxo-N-((tans)...)Show SMILES Cn1nccc1-c1ccc2OC3(CCN(CC3)C(=O)N[C@H]3C[C@@H]3c3ccccc3)CC(=O)c2c1 |r| Show InChI InChI=1S/C27H28N4O3/c1-30-23(9-12-28-30)19-7-8-25-21(15-19)24(32)17-27(34-25)10-13-31(14-11-27)26(33)29-22-16-20(22)18-5-3-2-4-6-18/h2-9,12,15,20,22H,10-11,13-14,16-17H2,1H3,(H,29,33)/t20-,22+/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Inhibition of CYP3A4 |
Bioorg Med Chem Lett 19: 3398-404 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.036 BindingDB Entry DOI: 10.7270/Q20C4VP7 |
More data for this Ligand-Target Pair | |
Sodium channel protein type 5 subunit alpha
(Homo sapiens (Human)) | BDBM50268434
((+/-)-6-(1-methyl-1H-pyrazol-5-yl)-4-oxo-N-((tans)...)Show SMILES Cn1nccc1-c1ccc2OC3(CCN(CC3)C(=O)N[C@H]3C[C@@H]3c3ccccc3)CC(=O)c2c1 |r| Show InChI InChI=1S/C27H28N4O3/c1-30-23(9-12-28-30)19-7-8-25-21(15-19)24(32)17-27(34-25)10-13-31(14-11-27)26(33)29-22-16-20(22)18-5-3-2-4-6-18/h2-9,12,15,20,22H,10-11,13-14,16-17H2,1H3,(H,29,33)/t20-,22+/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Inhibition of Voltage-gated sodium channel subunit alpha Nav1.5 |
Bioorg Med Chem Lett 19: 3398-404 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.036 BindingDB Entry DOI: 10.7270/Q20C4VP7 |
More data for this Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50268434
((+/-)-6-(1-methyl-1H-pyrazol-5-yl)-4-oxo-N-((tans)...)Show SMILES Cn1nccc1-c1ccc2OC3(CCN(CC3)C(=O)N[C@H]3C[C@@H]3c3ccccc3)CC(=O)c2c1 |r| Show InChI InChI=1S/C27H28N4O3/c1-30-23(9-12-28-30)19-7-8-25-21(15-19)24(32)17-27(34-25)10-13-31(14-11-27)26(33)29-22-16-20(22)18-5-3-2-4-6-18/h2-9,12,15,20,22H,10-11,13-14,16-17H2,1H3,(H,29,33)/t20-,22+/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Inhibition of CYP2C9 |
Bioorg Med Chem Lett 19: 3398-404 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.036 BindingDB Entry DOI: 10.7270/Q20C4VP7 |
More data for this Ligand-Target Pair | |